Nick Train Lindsell Train
Nick Train is a co-founder of Lindsell Train, a London-based firm known for concentrated ownership of high-quality consumer, media, and financial franchises. The firm favors long holding periods and businesses with durable brands or network effects. Train’s commentaries are popular among global quality investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$119M |
| 2 |
TKO Group
TKO
|
+$116M |
| 3 |
Walt Disney
DIS
|
+$104M |
| 4 |
Intuit
INTU
|
+$93.7M |
| 5 |
Fair Isaac
FICO
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 27.92% |
| 2 | Consumer Staples | 26.59% |
| 3 | Technology | 24.93% |
| 4 | Financials | 9.47% |
| 5 | Consumer Discretionary | 5.68% |
Similar funds
Nick Train's Q4 2024 Portfolio in Review
As of Q4 2024, Nick Train held 30 positions worth $4B, down 9.7% from $4.43B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Nick Train withdrew a net $397M in Q4 2024, closing 2 positions and reducing 11 holdings. Its most notable exit was Johnson & Johnson, an estimated $983K position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 27% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, Nick Train opened a new position in Thermo Fisher Scientific worth $212M.
- Nick Train's largest Q4 2024 buy was Thermo Fisher Scientific: 407,240 shares worth $212M.
- Nick Train's biggest Q4 2024 reduction was Mondelez International, cutting an estimated $119M.
- Nick Train fully exited Johnson & Johnson in Q4 2024, selling an estimated $983K.
- Nick Train's ten largest holdings make up 95% of its $4B portfolio in Q4 2024.
- Nick Train opened 1 new position and closed 2 in Q4 2024.
- Nick Train's portfolio value fell 9.7% quarter-over-quarter to $4B.
Based on Lindsell Train's 13F filing for Q4 2024, filed 21 Jan 2025.